Viewing data from:

ETHOSUXIMIDE

ANDA

ETHOSUXIMIDE | A200892 | HERITAGE PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.2523

per ea

Lowest NADAC/Unit

$0.2523

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
23155053201ETHOSUXIMIDE 250 MG CAPSULE	$0.2523	EA	Generic	—	2026-06-17
62135079012ETHOSUXIMIDE 250 MG CAPSULE	$0.2523	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

KATWIJK CHEMIE BVETHOSUXIMIDE

DMF 79371989

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 250MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Sep 25, 2012

No patent or exclusivity listings for this strength.